14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
CGNT vs CLBT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Cellebrite DI Ltd. Class A (CLBT) is the stronger overall head-to-head candidate over Cognyte Software Ltd. (CGNT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNT carries a Unified Composite Score of 49.9/100 (HOLD) at $7.76 (22.0x Forward P/E, 4.1% operating margin), whereas CLBT carries 41.0/100 (SELL) at $10.73 (16.6x Forward P/E, 11.9% operating margin).
Composite vs. Pillar Nuance: While CGNT currently prints a higher short-term Unified Composite Score (49.9/100 HOLD vs. CLBT 41.0/100 SELL), CLBT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 4.1% operating margin) and revenue trajectory (+18.2% vs. +12.0% YoY).
Technical & Structure Timing Caution: CGNT is currently in a Breakdown options structure phase (RSI 37.1); meanwhile CLBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Software - Infrastructure value chain with $2.9B market capitalization and 11.9% operating margin.
OpEx & R&D Reinvestment70.4% of Rev ($378M)
90D Engineering Disclosures0 Published
Investor FAQ CGNT vs CLBT Key Questions & Quantitative Answers
As of Nov 17, 2026, Cellebrite DI Ltd. Class A (CLBT) is the stronger overall head-to-head candidate over Cognyte Software Ltd. (CGNT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNT carries a Unified Composite Score of 49.9/100 (HOLD) at $7.76 (22.0x Forward P/E, 4.1% operating margin), whereas CLBT carries 41.0/100 (SELL) at $10.73 (16.6x Forward P/E, 11.9% operating margin). Composite vs. Pillar Nuance: While CGNT currently prints a higher short-term Unified Composite Score (49.9/100 HOLD vs. CLBT 41.0/100 SELL), CLBT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 4.1% operating margin) and revenue trajectory (+18.2% vs. +12.0% YoY). Technical & Structure Timing Caution: CGNT is currently in a Breakdown options structure phase (RSI 37.1); meanwhile CLBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CLBT leads the Growth & Scale pillar: CGNT posts +12.0% YoY revenue growth and +177.7% YoY earnings growth on $422M TTM revenue (73.0% gross margin, 4.1% operating margin), compared with CLBT at +18.2% YoY revenue growth and +25.0% YoY earnings growth on $537M TTM revenue (82.3% gross margin, 11.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CGNT cumulative revenue shifted -7.0% while CLBT shifted +182.4%. In operating R&D and SG&A reinvestment, CGNT deploys 68.9% of Rev ($291M) (0 90-day corporate R&D disclosures) versus 70.4% of Rev ($378M) (0 disclosures) for CLBT.
CGNT screens cheaper on headline valuation multiples. CGNT trades at 22.0x Forward P/E, 10.3x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (7.9% FCF margin), whereas CLBT trades at 16.6x Forward P/E, 46.1x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (26.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNT (2.2% ROE) versus CLBT (12.7% ROE) capital efficiency.
In options market volatility and institutional positioning, CGNT carries 53.3% implied volatility (56th %ile, Balanced (25th–60th %ile)), a 0.07x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.39β · 55% Vol realized risk). By comparison, CLBT carries 112.5% implied volatility (39th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.57β · 60% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.